[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100560871":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":56,"collaborators":60,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":66,"sex":72,"minAge":73,"maxAge":25,"enrollmentInfo":74,"targetDuration":25,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":25,"overallStatus":41,"whyStopped":25,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Medical University of South Carolina","OTHER",[8,13],{"label":9,"type":6,"description":10,"interventionNames":11},"Treatment as Usual","Participants in the treatment as usual group will be provided educational material about mood management available via the EHR with the suggestion to discuss questions with their oncology provider. Participants will be asked to complete questionnaire measures weekly for 8 weeks with a final follow up at 12 weeks.",[12],"Behavioral: Treatment as Usual",{"label":14,"type":15,"description":16,"interventionNames":17},"Moodivate","EXPERIMENTAL","Participants randomized to the Moodivate condition will be instructed to utilize Moodivate regularly, at least once per day, for the treatment of depressed mood among cancer survivors. Participants in the Moodivate group will receive a download code to download the Moodivate mobile application. Moodivate is a mobile app for individuals with elevated symptoms of depression. Within the app, users identify values, create activities, schedule activities, and rate mood daily. Participants will be asked to complete questionnaire measures weekly for 8 weeks with a final follow up at week 12.",[18],"Behavioral: Behavioral Activation Therapy App",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","Behavioral Activation Therapy App","Moodivate focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. Participants will be asked to complete questionnaire measures weekly for 8 weeks, with a final follow-up questionnaire at 12 weeks following study enrollment.",[14],null,{"type":21,"name":9,"description":27,"armGroupLabels":28,"otherNames":25},"Participants will be provided educational material about mood management available via the EHR with the suggestion to discuss questions with their oncology provider. Participants will be asked to complete questionnaire measures weekly for 8 weeks with a final follow up at week 12.",[9],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":25,"email":34},"Jennifer Dahne, Ph.D.","CONTACT","843-876-2280","dahne@musc.edu",{"name":36,"role":32,"phone":37,"phoneExt":25,"email":38},"Noelle Natale","843-876-9457","natalen@musc.edu",[40],{"facility":5,"status":41,"city":42,"state":43,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"RECRUITING","Charleston","South Carolina","29425","United States","US",{"type":48,"coordinates":49},"Point",[50,51],-79.93275,32.77632,{"lat":51,"lon":50},[54],{"name":55,"role":32,"phone":33,"phoneExt":25,"email":34},"Jennifer Dahne, PhD",{"type":57,"investigatorFullName":58,"investigatorTitle":59,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Jennifer Dahne","Associate Professor-Faculty",[61],{"name":62,"class":63},"National Cancer Institute (NCI)","NIH","100560871","impact-improving-proactive-approaches-for-cancer-survivors-mental-health-treatment-100560871",false,"NCT06582784","IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)","Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living With Likely Incurable Cancer","IMPACT","Inclusion Criteria:\n\n* Age \\> 18 years\n* ILLIC (as determined during manual chart review)\n* Elevated depressive symptoms, defined as a score of ≥ 8 on the PHQ-9\n* Current owner of an iOS- or Android-compatible smartphone\n* Willingness to utilize a mobile app for the treatment of depressed mood (response of \"yes\" on yes\u002Fno item)\n* Have a valid e-mail address that is checked regularly or have regular access to text messages (to access follow-up assessments)\n* English language fluency\n\nExclusion Criteria:\n\n* Current suicidal ideation at study screening, defined as a response greater than or equal to 1 on item nine of the PHQ-9\n* Severe cognitive impairment that precludes completion of informed consent. For the purposes of assessing eligibility, this criterion is operationalized as:\n* Prior diagnosis of dementia, or Major Neurocognitive Disorder indicated either via self-report or in the EHR; or\n* Self-report of cognitive difficulties that impair functional independence","ALL","18 Years",{"count":75,"type":76},279,"ESTIMATED","INTERVENTIONAL",[79],"NA","The purpose of this research study is to evaluate a mobile application (app) for depression treatment called \"Moodivate\" among cancer survivors. Moodivate was developed by our research team to assist with the treatment of depressed mood.\n\nParticipants will be randomly assigned to either download the mobile app, \"Moodivate\", or not. Approximately 2\u002F3 of participants enrolled will receive the mobile app and the remaining 1\u002F3 will not.\n\nAll participants will complete electronic questionnaire measures throughout the study period. Questionnaires will assess symptoms of depression, as well as your experiences using Moodivate and participating in this trial. Participation in this study will take about 12 weeks, beginning today.\n\nParticipation in this study may help in the treatment of future cancer survivors. The greatest risks of this study include frustration, worsening of emotional distress, data breach, and\u002For loss of confidentiality. Alternative treatments include contacting your primary care provider or your oncology care team to discuss other available treatments for depressed mood.",[82,83,84],"Depression","Depressive Symptoms","Cancer","2026-05-19",{"date":87,"type":88},"2026-05-22","ACTUAL",{"date":90,"type":88},"2024-10-28",{"date":92,"type":76},"2028-09-01",{"name":5,"class":6},1]